Department of Biomedical Engineering, National Cheng Kung University, Tainan 701, Taiwan.
Department of Ophthalmology, National Cheng Kung University Hospital, Tainan 701, Taiwan.
Biosensors (Basel). 2020 Sep 23;10(10):130. doi: 10.3390/bios10100130.
Handy and disposable point-of-care diagnostics facilitate the early screening of severe diseases in resource-limited areas. To address urgent needs in inconvenient sites, a simple colorimetric diagnostic device equipped with a capillary tube with porous hydrogel and immunocomplex particles was developed for the rapid detection of biomarkers (16 min). In this device, probe particles attach to capture particles (dp = 40 µm) and form sandwiched immunocomplexes in the presence of target biomarkers, and a red color progressively emerges when the sandwiched immunocomplex particles are blocked by the porous hydrogel embedded inside the glass capillary. Colorimetric aggregation was recorded using a smartphone and analyzed with imaging software. The limit of detection reached 1 ng/mL and showed a maximum of 79% accuracy compared with that obtained through a conventional spectrophotometric technique. The level of a diabetic retinopathy (DR) biomarker, lipocalin-1 (LCN-1), was measured in 1 µL of a human tear sample and used in testing the practicability of the proposed device. All healthy subjects showed lower intensity levels than the other diabetic counterparts (proliferative DR or nonproliferative DR patients), implying the potential of this device in clinical applications. Overall, the diagnostic device facilitates point-of-care-testing and provides a low-cost (~1 USD), compact, and reliable tool for early diagnosis in resource-limited areas.
便捷且一次性使用的即时检测诊断技术有助于在资源有限的地区对严重疾病进行早期筛查。为了满足偏远地区紧急检测的需求,我们开发了一种简单的比色诊断设备,该设备配备带有多孔水凝胶和免疫复合物颗粒的毛细管,用于快速检测生物标志物(16 分钟)。在该设备中,探测颗粒与捕获颗粒(dp = 40 µm)结合,并在存在目标生物标志物的情况下形成夹心免疫复合物,当夹芯免疫复合物颗粒被嵌入玻璃毛细管内部的多孔水凝胶阻挡时,红色逐渐出现。使用智能手机记录比色聚集,并使用成像软件进行分析。检测限达到 1 ng/mL,与传统分光光度技术相比,准确率最高可达 79%。在 1 µL 人泪样本中测量了糖尿病视网膜病变 (DR) 生物标志物——脂质运载蛋白-1 (LCN-1) 的水平,并测试了所提出设备的实用性。所有健康受试者的强度水平均低于其他糖尿病患者(增殖性 DR 或非增殖性 DR 患者),这意味着该设备具有在临床应用中的潜力。总的来说,这种诊断设备便于即时检测,并为资源有限地区的早期诊断提供了一种低成本(约 1 美元)、紧凑且可靠的工具。